Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash from Operations (Quarterly): -11.03M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -11.03M |
| June 30, 2023 | -10.04M |
| March 31, 2023 | -18.63M |
| December 31, 2022 | -9.937M |
| September 30, 2022 | -7.226M |
| June 30, 2022 | -8.098M |
| Date | Value |
|---|---|
| March 31, 2022 | -7.684M |
| December 31, 2021 | -9.914M |
| September 30, 2021 | -5.321M |
| June 30, 2021 | -6.758M |
| March 31, 2021 | -5.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.63M
Minimum
Mar 2023
-5.20M
Maximum
Mar 2021
-9.076M
Average
-8.098M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -111.06M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -4.881M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 10.08M |
| Free Cash Flow | -49.70M |
| Free Cash Flow Per Share (Quarterly) | -0.2529 |